Chicago Atlantic Real Estate Finance, Inc.REFI

Chicago Atlantic Real Estate Finance, Inc. (REFI) just filed its 10-Q for the quarter ended 31 March 2026, and the numbers tell a quieter tale than the deal-hungry press releases suggest. Net income attributable to parent clocked in at $4.8 million, while cash and cash equivalents sat at $27.9 million and stockholders’ equity stood at $303.4 million against total liabilities of $132.5 million. Earnings per share, diluted, printed at $0.23 on 21.5 million diluted shares, a figure that would look more impressive if the company weren’t still chasing stockholder and regulator approvals for a merger that has already generated four separate 425 filings in three weeks.

REFI pitches itself as a provider of “financing solutions” and “investment strategies,” but the real engine is the real-estate lending pipeline built on cannabis collateral. The latest filings note that Chicago Atlantic Group’s cannabis real estate pipeline totalled $113 million in the first quarter, while the combined group’s lending pipeline reached $482 million-a neat 4.3× ratio that sounds impressive until you recall that every loan is matched by a liability and every property can be re-let, sold, or seized. The product pages carry the usual wave imagery and the requisite disclaimer that SEC registration does not imply skill, but the balance sheet is the only place where the promise turns into receivables and cash.

The operating cash flow for the quarter was a modest $3.2 million, which is enough to keep the cogs turning but not enough to fund a shopping spree. Net cash provided by operating activities is the closest thing to a sine qua non for a lender, and at $3.2 million REFI is generating cash in line with its current scale, yet the filing flags that both REFI and its merger partner must keep sourcing new lending opportunities just to service existing obligations. That’s not a flaw in the model; it’s the model. The tension is whether the pipeline converts to cash before liquidity needs spike.

The company’s SEC filing index and company facts JSON confirm the parade of 425s, DEFA14A, and 10-Qs, but none of them answer the liquidity question that matters: how soon will the merger close, and what happens to the $132.5 million of liabilities if it doesn’t? The merger is described as subject to “required stockholder approvals, regulatory approvals, and customary closing conditions,” a phrase that sounds reassuring until you realise it’s corporate legal for “we still need sign-off from two sets of owners and a regulator who might ask for more filing trail.” Meanwhile, the product rails and marketing pages remain untouched by the filing reality, offering waveless waves and disclaimers rather than cash-flow clarity.

Chicago Atlantic’s website still hosts the same glossy product pages and strategy write-ups, but the only image that really explains the moment is the 10-Q’s line items: $27.9 million in cash, $132.5 million in liabilities, and a net income that disappears into the noise when set against the merger’s closing risk. The story isn’t the financing solutions or the investment strategies; it’s whether the filing trail finishes before the cash runway does.